Results 191 to 200 of about 22,488 (214)

The dynamic interplay between viruses and host non-coding RNA species. [PDF]

FEMS Microbiol Rev
Matandirotya L, Burke L, Dimascio E, Menezes S, Allott K, Whitehouse A.   +5 more
europepmc   +1 more source

Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation. [PDF]

J Med Virol
Wan Q, Tucker AJ, Zhao J.
europepmc   +1 more source

Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, Uganda. [PDF]

Open Forum Infect Dis
Ssempijja V, Callier V, Nason M, Anok A, Lisco A, Redd AD, Quinn TC, Rupert A, Towlerton A, Das S, Walker L, Tomusange S, Kityamuweesi T, Bbuule P, Sereti I, Reynolds SJ.   +15 more
europepmc   +1 more source

Human and viral chemokines differentially modulate G protein signaling, β-arrestin recruitment and chemotaxis mediated by the viral G protein-coupled receptor ORF74. [PDF]

Cell Commun Signal
Kong Q, Van Bosstraeten B, Jacquemyn M, Daelemans D, De Jonghe S, Schols D, Van Loy T.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

KSHV/HHV8-mediated hematologic diseases

Blood, 2022
Abstract Kaposi sarcoma (KS) herpesvirus (KSHV), also known as human herpesvirus 8, is the causal agent of KS but is also pathogenetically related to several lymphoproliferative disorders, including primary effusion lymphoma (PEL)/extracavitary (EC) PEL, KSHV-associated multicentric Castleman disease (MCD), KSHV+ diffuse large B-cell ...
Ethel Cesarman, Amy Chadburn, Paul G. Rubinstein   +2 more
openaire   +2 more sources

Immunotherapy for KSHV-associated diseases

Current Opinion in Virology, 2022
Kaposi sarcoma herpesvirus (KSHV)-associated diseases (Kaposi sarcoma, multicentric Castleman disease, primary effusion lymphoma, and KSHV inflammatory cytokine syndrome) are associated with immune suppression and dysregulation and loss of KSHV-specific immunity.
Kathryn, Lurain, Robert, Yarchoan, Ramya, Ramaswami   +2 more
openaire   +2 more sources

Linking KSHV to human cancer

Current Oncology Reports, 2005
Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), has been linked to several malignancies in humans. KSHV is the etiologic agent associated with the development of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman's disease (MCD). KSHV is a double-stranded DNA virus that has been
Emily L, Wong, Blossom, Damania
openaire   +2 more sources

KSHV Immune Evasion

2008
Kaposi’s sarcoma-associated herpesvirus (KSHV) has been consistently implicated in the pathogenesis of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease (MCD). The hallmark of KSHV infection is to establish life-long persistency that has imposed enormous pressure on this virus to escape host immune recognition.
Chengyu Liang, Hyera Lee, Liguo Wu, Pinghui Feng, Jae U. Jung   +4 more
openaire   +1 more source

KSHV infection of B-cell lymphoma using a modified KSHV BAC36 and coculturing system

The Journal of Microbiology, 2012
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of two B cell lymphoproliferative diseases, namely primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). KSHV infection of B cell lymphoma in vitro has been a long-standing battle in advancing human KSHV biology.
Hyosun, Cho, Hyojeung, Kang
openaire   +2 more sources

KSHV-induced oncogenesis

2007
Human infection by KSHV is associated with the development of at least three proliferative disorders: Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL) and a subset of multicentric Castleman’s disease (MCD). In keeping with the classification of KSHV as a lymphotropic (γ2) herpesvirus, two of these (PEL and MCD) are primary disorders of the B cell
openaire   +1 more source